NCT05040308View on ClinicalTrials.gov

Uganda PrEP and Harm Reduction Evaluation

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
HIV-1-infection
Interventions
OTHER

Integrating PrEP delivery

Integration of PrEP delivery services in NSP and MAT programs

Trial Locations (1)

Unknown

Infectious Diseases Institute, Makerere University, Kampala

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Makerere University

OTHER

lead

University of Washington

OTHER